Martine Reindle, serial entrepreneur and former Mymetics Board member worked previously with Urs Amstutz, Founder and former CEO of Stallergènes on Abionic’s Board of Directors. http://www.finsmes.com/2014/10/abionic-closes-chf3-8m-series-b-financing.html https://rocketreach.co/stallergenes-profile_b5c6762af42e0c8b http://abionic.com/en https://www.fiercebiotech.com/biotech/mymetics-appoints-grant-pickering-ceo-and-christopher-henney-chairman Safe weekend to all.
Market Data 
Markets
AI
